1107627-01-9 Usage
General Description
1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazole is a chemical compound with a complex structure. It contains a benzimidazole ring with a methyl group at the 1 position and a boron-containing group at the 6 position. The boron group is specifically a 4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl group. 1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazole has potential applications in medicinal chemistry, particularly in the development of pharmaceuticals and agrochemicals. It may also be used as a building block in organic synthesis or as a research reagent in chemical and biological studies. The unique structure and properties of this compound make it an interesting target for further study and potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1107627-01-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,7,6,2 and 7 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1107627-01:
(9*1)+(8*1)+(7*0)+(6*7)+(5*6)+(4*2)+(3*7)+(2*0)+(1*1)=119
119 % 10 = 9
So 1107627-01-9 is a valid CAS Registry Number.
1107627-01-9Relevant articles and documents
PRMT5 INHIBITORS AND USES THEREOF
-
, (2016/04/20)
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof:wherein Y1 is of formula (?) or formula (y):Ring Y is a 5- to 6-membered heteroaryl ring; and V4, V5, Rx, x, y, and n are as defined herein. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
